(Q47350555)

English

Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone

scientific article published on 7 October 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

0 references

1 reference

based on heuristic

inferred from title

Zoran Radojicic

8

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

author name string

Mirjana Doknic

1

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Nadja P Maric

2

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Dubravka Britvic

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Sandra Pekic

4

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Aleksandar Damjanovic

5

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Dragana Miljic

6

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Marko Stojanovic

7

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Miroslava Jasovic Gasic

9

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Vera Popovic

10

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

publication date

7 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Neuroendocrinology

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

94

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

246-254

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Risk of hip fracture in patients with a history of schizophrenia.

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Bone mass in schizophrenia and normal populations across different decades of life

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Molecular bases of the sympathetic regulation of bone mass

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

The central regulation of bone mass, the first link between bone remodeling and energy metabolism

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Effect of selective serotonin reuptake inhibitors on the risk of fracture

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Regulation of bone remodeling by the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

The osteoblast: a sophisticated fibroblast under central surveillance

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Enhanced trabecular-bone calcium deposition in female rats with a high physiological dose of prolactin diminishes after ovariectomy

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Atypical antipsychotics and pituitary tumors: a pharmacovigilance study

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Short-term treatment with olanzapine does not modulate gut hormone secretion: olanzapine disintegrating versus standard tablets

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Bone mineral density in male schizophrenia patients: a review

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Prolactin awareness: an essential consideration for physical health in schizophrenia.

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Osteoporosis in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

High bone turnover but normal bone mineral density in women suffering from schizophrenia

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Cumulative exposure to estrogen and psychosis: a peak bone mass, case-control study in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women.

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Bone mineral density during reduction, maintenance and regain of body weight in premenopausal, obese women

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents

1 reference

https://api.crossref.org/works/10.1159%2F000329391

21 January 2018

Identifiers

10.1159/000329391

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21986470

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47350555&oldid=2153210920"